Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
13.12
-1.01 (-7.15%)
At close: Nov 20, 2024, 4:00 PM
13.04
-0.08 (-0.61%)
Pre-market: Nov 21, 2024, 7:19 AM EST
Intellia Therapeutics Market Cap
Intellia Therapeutics has a market cap or net worth of $1.34 billion as of November 21, 2024. Its market cap has decreased by -48.79% in one year.
Market Cap
1.34B
Enterprise Value
493.20M
1-Year Change
-48.79%
Ranking
Category
Stock Price
$13.12
Market Cap Chart
Since May 6, 2016, Intellia Therapeutics's market cap has increased from $757.50M to $1.34B, an increase of 76.40%. That is a compound annual growth rate of 6.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 1.34B | -51.06% |
| Dec 29, 2023 | 2.73B | -0.54% |
| Dec 30, 2022 | 2.75B | -68.80% |
| Dec 31, 2021 | 8.80B | 173.78% |
| Dec 31, 2020 | 3.21B | 348.19% |
| Dec 31, 2019 | 717.10M | 20.99% |
| Dec 31, 2018 | 592.70M | -14.55% |
| Dec 29, 2017 | 693.60M | 46.98% |
| Dec 30, 2016 | 471.90M | -37.70% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Travere Therapeutics | 1.51B |
| Kiniksa Pharmaceuticals International, | 1.50B |
| InMode | 1.50B |
| BioCryst Pharmaceuticals | 1.49B |
| Arvinas | 1.49B |
| Bicycle Therapeutics | 1.41B |
| Harrow | 1.41B |
| Ocular Therapeutix | 1.40B |